We serve Chemical Name:1-oxido-2,1,3-benzoxadiazol-1-ium-5-carbaldehyde CAS:19164-42-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-oxido-2,1,3-benzoxadiazol-1-ium-5-carbaldehyde
CAS.NO:19164-42-2
Synonyms:5-Formylbenzofuroxan;2,1,3-BENZOXADIAZOLE-5-CARBOXALDEHYDE,1-OXIDE;2,1,3-BENZOXADIAZOLE-5-CARBALDEHYDE 1-OXIDE;5-benzofuroxanaldehyde
Molecular Formula:C7H4N2O3
Molecular Weight:164.11800
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:335.4ºC at 760mmHg
Density:1.56g/cm3
Index of Refraction:1.685
PSA:68.56000
Exact Mass:164.02200
LogP:1.06880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Formylbenzofuroxan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-benzofuroxanaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Formylbenzofuroxan Use and application,2,1,3-BENZOXADIAZOLE-5-CARBALDEHYDE 1-OXIDE technical grade,usp/ep/jp grade.
Related News: The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. anti-benzoylformic acid acetylhydrazone manufacturers But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. 2-(2-(4,6-bis((2,4-dimethylphenyl)amino)-1,3,5-triazin-2-yl)hydrazineyl)-1-methyl-6-oxo-4-phenyl-1,6-dihydropyrimidine-5-carbonitrile suppliers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. 6-(5-ethyl-1,3,4-thiadiazol-2-ylthiomethyl)-4-morpholino-2-{1-[3-(2-propenyloxycarbonylamino)phenyl]butylamino}pyridine vendor & factory.
